Studies of in vitro activated CD5+ B cells

Area of Science:

• Immunology
• Cell Biology
• B cell immunology

Background:

• Human B lymphocytes exhibit phenotypic plasticity upon activation.
• A distinct subpopulation of B cells expresses the CD5 antigen, prompting investigation into its origins.
• Understanding B cell activation pathways is crucial for immunology research.

Purpose of the Study:

• To identify specific signals that induce CD5 expression on normal splenic B cells.
• To characterize the phenotype and function of CD5-expressing B cells.
• To elucidate the role of TPA in B cell activation and CD5 expression.

Main Methods:

• Purification of human splenic B cells.
• Stimulation of B cells with various agents including TPA, anti-immunoglobulin, and cytokines.
• Detection of CD5 expression using flow cytometry.
• Dual-fluorochrome analysis to assess co-expression of activation markers.
• In vitro functional assays measuring tritiated thymidine incorporation and immunoglobulin secretion.

Main Results:

• Only 12-O-tetradecanoylphorbol-13-acetate (TPA) induced CD5 expression on purified splenic B cells.
• CD5 expression was detectable by 48 hours and diminished by 96 hours post-TPA stimulation.
• TPA-induced CD5+ B cells coexpressed activation markers like B5, IL-2 receptor, and CD23.
• TPA-stimulated CD5- B cells showed higher proliferation and immunoglobulin secretion compared to CD5+ B cells.

Conclusions:

• TPA is a potent inducer of CD5 expression on human B cells.
• TPA-induced CD5+ B cells represent an activated B lymphocyte subset.
• The functional differences between CD5- and CD5+ B cells suggest distinct roles in immune responses.